Clinical and molecular genetic features of Hb H and AE Bart’s diseases in central Thai children
Open Access
- 1 April 2018
- journal article
- research article
- Published by Taylor & Francis in The Application of Clinical Genetics
- Vol. ume 11, 23-30
Abstract
Clinical and molecular genetic features of Hb H and AE-Bart’s diseases in central Thai children Chanchai Traivaree,1,* Boonchai Boonyawat,2,* Chalinee Monsereenusorn,1 Piya Rujkijyanont,1 Apichat Photia1 1Division of Hematology/Oncology, Department of Pediatrics, Phramongkutklao Hospital and College of Medicine, Bangkok, Thailand; 2Division of Genetics, Department of Pediatrics, Phramongkutklao Hospital and College of Medicine, Bangkok, Thailand *These authors contributed equally to this work Background: α-Thalassemia, one of the major thalassemia types in Thailand, is caused by either deletion or non-deletional mutation of one or both α-globin genes. Inactivation of three α-globin genes causes hemoglobin H (Hb H) disease, and the combination of Hb H disease with heterozygous hemoglobin E (Hb E) results in AE Bart’s disease. Objective: This study aimed to characterize the clinical and hematological manifestations of 76 pediatric patients with Hb H and AE Bart’s diseases treated at Phramongkutklao Hospital, a tertiary care center for thalassemia patients in central Thailand.Patients and methods: Seventy-six unrelated pediatric patients, 58 patients with Hb H disease and 18 patients with AE Bart’s disease, were enrolled in this study. Their clinical presentations, transfusion requirement, laboratory findings, and mutation analysis were retrospectively reviewed and analyzed.Results: A total of 76 pediatric patients with Hb H and AE Bart’s diseases who mainly lived in central Thailand were included in this study. The clinical severities of patients with non-deletional mutations were more severe than those with deletional mutations. Eighty-six percent of patients with non-deletional AE Bart’s disease required more blood transfusion compared to 12.5% of patients with deletional AE Bart’s disease. Non-deletional AE Bart’s disease also had a history of urgent blood transfusion with the average of 6±0.9 times compared to 1±0.3 times in patients with deletional Hb H disease. The difference was statistically significant.Conclusion: This study revealed the differences in clinical spectrum between patients with Hb H disease and those with AE Bart’s disease in central Thailand. The differentiation of α-thalassemia is essential for appropriate management of patients. The molecular diagnosis is useful for diagnostic confirmation and genotype–phenotype correlation. Keywords: genotype, phenotype, Hb H disease, AE Bart’s disease, Thai childrenKeywords
This publication has 22 references indexed in Scilit:
- Heterogeneity of Hemoglobin H Disease in ChildhoodNew England Journal of Medicine, 2011
- Hb H disease: clinical course and disease modifiersHematology-American Society Hematology Education Program, 2009
- A scoring system for the classification of β‐thalassemia/Hb E disease severityAmerican Journal of Hematology, 2008
- The Diverse Molecular Basis and Hematological Features of Hb H and AEBart’s Diseases in Northeast ThailandActa Haematologica, 2004
- Hemoglobin H disease: not necessarily a benign disorderBlood, 2003
- Genetic and Clinical Features of Hemoglobin H Disease in Chinese PatientsNew England Journal of Medicine, 2000
- Molecular defects in Hb H hydrops fetalisBritish Journal of Haematology, 1997
- Different hematologic phenotypes are associated with the leftward (-alpha 4.2) and rightward (-alpha 3.7) alpha+-thalassemia deletions.Journal of Clinical Investigation, 1987
- Serum Ferritin Levels in Hemoglobin H DiseaseActa Haematologica, 1983
- Incidence of haemoglobin Thai: a re‐examination of the genetics of α‐thalassaemic diseasesAnnals of Human Genetics, 1972